SEARCH

SEARCH BY CITATION

References

  • 1
    Weinblatt ME, Coblyn JS, Fox DA, Holdsworth DE, Glass DN, Trentham DE: Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med 312: 818822, 1985
  • 2
    Williams JH, Willkens RF, Samuelson CO Jr, Alarcon GS, Guttadauria M, Yarboro C, Polisson RP, Weiner SR, Luggen ME, Billingsley LM, Dahl SL, Egger MJ, Reading JC, Ward JR: Comparison of low-dose oral pulse methotrexate and placebo in the treatment of rheumatoid arthritis: a controlled clinical trial. Arthritis Rheum 28: 721730, 1985
  • 3
    Andersen PA, West SG, O'Dell JR, Via CS, Claypool RG, Kotzin BL: Weekly pulse methotrexate in rheumatoid arthritis: clinical and immunologic effects in a randomized, double-blind study. Ann Intern Med 103: 489496, 1985
  • 4
    Weinstein A, Marlowe S, Korn J, Faronhar F: Low dose methotrexate treatment of rheumatoid arthritis: long-term observations. Am J Med 79: 331337, 1985
  • 5
    Hoffmeister RT: Methotrexate therapy in rheumatoid arthritis: 15 years experience. Am J Med 12: 6973, 1983
  • 6
    Willkens RF, Watson MA: Methotrexate: a perspective of its use in the treatment of rheumatic diseases. J Lab Clin Med 100: 314321, 1982
  • 7
    Kremer JM, Lee JK: The safety and efficacy of the use of methotrexate in long-term therapy for rheumatoid arthritis. Arthritis Rheum 29: 822831, 1986
  • 8
    Weinblatt ME, Trentham DE, Fraser PA, Holdsworth DE, Falchuk KR, Weissman BN, Coblyn JS: Long-term prospective trial of low-dose methotrexate in rheumatoid arthritis. Arthritis Rheum 31: 167175, 1988
  • 9
    Kremer JM, Lee JK: A long-term prospective study of the use of methotrexate in rheumatoid arthritis: update after a mean of fifty-three months. Arthritis Rheum 31: 577584, 1988
  • 10
    Furst DE, Erikson N, Clute L, Kochnke R, Burmeister LF, Kohler JA: Adverse experience with methotrexate during 176 weeks of long-term prospective trial in patients with rheumatoid arthritis. J Rheumatol 17: 16281635, 1990
  • 11
    Wolfe F, Hawley DJ, Cathey MA: Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14 year prospective evaluation of 1017 consecutive starts. J Rheumatol 17: 9941002, 1990
  • 12
    Kremer JM, Rynes RI, Bartholomew LE: Severe flare of rheumatoid arthritis after discontinuation of long-term methotrexate therapy: double-blind study. Am J Med 82: 781786, 1987
  • 13
    Weinstein G, Roenigk HH, Maibach K, Cosmides J, Halprin K, Millard M: Psoriasis-liver methotrexate interactions. Arch Dermatol 108: 3642, 1973
  • 14
    Nyfors A: Liver biopsies from psoriatics related to methotrexate therapy: findings in post-methotrexate liver biopsies from 160 psoriatics. Acta Pathol Scand 85: 511514, 1977
  • 15
    Zachariae H, Kragballe K, Sogaard H: Methotrexate-induced liver cirrhosis: studies including serial liver biopsies during continued treatment. Br J Dermatol 102: 407412, 1980
  • 16
    Shergy WJ, Polisson RP, Caldwell DS, Rice JR, Pisetsky DS, Allen NB: Methotrexate-associated hepatotoxicity: retrospective analysis of 210 patients with rheumatoid arthritis. Am J Med 85: 771774, 1988
  • 17
    Aponte J, Petrelli M: Histopathologic findings in the liver of rheumatoid arthritis patients treated with long-term bolus methotrexate. Arthritis Rheum 31: 14571464, 1988
  • 18
    Rau R, Karger T, Herborn G, Frenzel H: Liver biopsy findings in patients with rheumatoid arthritis undergoing long-term treatment with methotrexate. J Rheumatol 16: 489493, 1989
  • 19
    Kremer JM, Lee RG, Tolman KG: Liver histology in rheumatoid arthritis patients receiving long-term methotrexate therapy: a prospective study with baseline and sequential biopsy samples. Arthritis Rheum 32: 121127, 1989
  • 20
    Brick JE, Moreland LW, Al-Kawas F, Chang WWL, Layne RD, di Bartolomeo AG: Prospective analysis of liver biopsies before and after methotrexate therapy in rheumatoid patients. Semin Arthritis Rheum 19: 3144, 1989
  • 21
    Wilske K, Healey L: Remodeling the pyramid: a concept whose time has come. J Rheumatol 16: 565567, 1989
  • 22
    Fries JF, Bloch DA, Sharp JT, McShane DJ, Spitz P, Bluhm GB, Forrester D, Genant H, Gofton P, Richman S, Weissman B, Wolfe F: Assessment of radiologic progression in rheumatoid arthritis. a randomized, controlled trial. Arthritis Rheum 29: 19, 1986
  • 23
    Steinbrocker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. JAMA 140: 659662, 1949
  • 24
    Weinblatt ME, Kaplan H, Germain BF, Merriman RC, Solomon SD, Wall B, Anderson L, Block S, Small R, Wolfe F, Gall E, Torretti D, Polisson R: Methotrexate in rheumatoid arthritis: effects on disease activity in a multicenter prospective study. J Rheumatol 18: 334338, 1991
  • 25
    Alarcón GS, Tracy IC, Blackburn WD Jr: Methotrexate in rheumatoid arthritis: toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum 32: 671676, 1989
  • 26
    Kremer JM, Galivan J, Streckfuss A, Kremer JM, Galivan J, Streckfuss A, Kamen B: Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients: association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 29: 832835, 1986
  • 27
    Morgan SL, Baggott JE, Vaughn WH, Young PK, Austin JV, Krumdieck CL, Alarcón GS: The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum 33: 918, 1990
  • 28
    Boh L, Schuna A, Pitterle M, Adams E, Sundstrom W: Long-term use of methotrexate in inflammatory arthritis: clinical and x-ray evaluation (abstract). Arthritis Rheum 28 (suppl 4): S46, 1985
  • 29
    Nordstrom DM, West SG, Andersen PA, Sharp JT: Pulse methotrexate therapy in rheumatoid arthritis: a controlled prospective roentgenographic study. Ann Intern Med 107: 797801, 1987
  • 30
    Hanrahan PS, Scrivens GA, Russell AS: Prospective long-term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol 28: 147153, 1989
  • 31
    López-Méndez A, Tracy I, Alarcón GS, Daniel WW: Disease progression in rheumatoid arthritis during methotrexate (MTX) administration: a radiological study (abstract). Arthritis Rheum 32 (suppl 1): R43, 1989
  • 32
    Sany J, Kaliski S, Couret M, Cuchacovich M, Daures J-P: Radiologic progression during intramuscular methotrexate treatment of rheumatoid arthritis. J Rheumatol 17: 16361641, 1990
  • 33
    Furst DE, Koehnke R, Burmeister LF, Kohler J, Cargill J: Increasing methotrexate effect with increasing dose in the treatment of resistant rheumatoid arthritis. J Rheumatol 16: 313320, 1989
  • 34
    Golden MR, Katz RS, Balk RA, Neu J, Golden H: The relationship of pre-existing lung disease to the occurrence of methotrexate pneumonitis in rheumatoid arthritis patients. Arthritis Rheum 33 (suppl 9): S40, 1990
  • 35
    Cannon GW, Ward JR, Clegg DO, Samuelson CO Jr, Abbott TM: Acute lung disease associated with low-dose pulse methotrexate therapy in patients with rheumatoid arthritis. Arthritis Rheum 26: 12691274, 1983